Clinical Trial Update: Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is recruiting to evaluate an allopregnanolone regenerative therapeutic for mild Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: University of Arizona | Conditions: Alzheimer Dementia, Late Onset Alzheimer Disease | Phase 2 | Status: RECRUITING